covid vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen.
The British-Swedish drugmaker's preliminary trial results mark a fresh breakthrough in the fight against a pandemic that has killed nearly 1.4 million people and roiled the global economy.
Earlier this week, Pfizer and Moderna had reported promising results from vaccine trials.“Today marks an important milestone in our fight against the pandemic.
This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency," AstraZeneca chief executive Pascal Soriot said in a statement.